Related Experiment Video
Updated: Jul 29, 2026
Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
Published on: November 3, 2014
Expression of inflammatory cytokines by murine macrophages activated with a new synthetic lipopeptide JT3002
1Department of Cell Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Abstract:
The present study was undertaken to investigate the effect of JT3002, a new synthetic analogue of a lipoprotein from the outer wall of a gram-negative bacterium on the production of cytokines by mouse peritoneal macrophages. Multilamellar liposomes containing different concentrations of JT3002 induced production of the inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 alpha, and interleukin-6 by macrophages in dose- and time-dependent manners. The presence of interferon-gamma enhanced production of tumor necrosis factor-alpha by macrophages exposed to lower concentrations of JT3002 and induced the release of nitric oxide, a potent cytolytic molecule of activated macrophages. Unlike lipopolysaccharide, JT3002 activated macrophages independently of serum, but like lipopolysaccharide, it required protein tyrosine kinase.
Insights
JT3002, a synthetic lipoprotein analogue, stimulates macrophages to produce inflammatory cytokines like tumor necrosis factor-alpha. It also induces nitric oxide release, especially when combined with interferon-gamma, activating immune responses.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Background:
- Lipoproteins from gram-negative bacteria are crucial in immune responses.
- Understanding novel synthetic analogues like JT3002 is vital for immune modulation research.
Purpose of the Study:
- To investigate the immunomodulatory effects of JT3002 on mouse peritoneal macrophages.
- To determine the impact of JT3002 on cytokine and nitric oxide production.
Main Methods:
- Macrophages were treated with JT3002 encapsulated in multilamellar liposomes.
- Cytokine production (TNF-α, IL-1α, IL-6) and nitric oxide release were measured.
- The role of interferon-gamma and protein tyrosine kinase was assessed.
Main Results:
- JT3002 induced dose- and time-dependent production of TNF-α, IL-1α, and IL-6.
- Interferon-gamma enhanced TNF-α production and induced nitric oxide release.
- JT3002 activated macrophages independently of serum but required protein tyrosine kinase.
Conclusions:
- JT3002 is a potent stimulator of macrophage inflammatory cytokine production.
- JT3002 exhibits unique activation properties distinct from lipopolysaccharide.
- This synthetic analogue holds potential for modulating immune responses.
More Related Videos
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
